Praxis Home Retail Limited
Praxis Home Retail Limited (PRAXIS.BO) Stock Competitors & Peer Comparison
See (PRAXIS.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Specialty Retail Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PRAXIS.BO | ₹5.60 | -3.45% | 1B | 2.73 | ₹2.02 | N/A |
| ETERNAL.BO | ₹229.05 | -5.43% | 2.1T | 971.25 | ₹0.24 | N/A |
| ZOMATO.NS | ₹215.19 | +0.00% | 2T | 286.92 | ₹0.75 | N/A |
| ZOMATO.BO | ₹215.25 | +0.00% | 2T | 377.63 | ₹0.57 | N/A |
| SWIGGY.NS | ₹260.05 | -6.00% | 697.3B | -14.42 | -₹18.62 | N/A |
| SWIGGY.BO | ₹259.85 | -6.09% | 696.1B | -14.40 | -₹18.62 | N/A |
| NYKAA.NS | ₹235.00 | -3.73% | 686.2B | 489.08 | ₹0.49 | N/A |
| NYKAA.BO | ₹235.20 | -3.61% | 685.9B | 488.88 | ₹0.49 | N/A |
| AVL.NS | ₹478.10 | -0.47% | 63.2B | 57.22 | ₹8.55 | +0.22% |
| REDTAPE.NS | ₹109.93 | -4.56% | 62.4B | 29.41 | ₹3.84 | +0.66% |
Stock Comparison
PRAXIS.BO vs ETERNAL.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, ETERNAL.BO has a market cap of 2.1T. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while ETERNAL.BO trades at ₹229.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas ETERNAL.BO's P/E ratio is 971.25. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ETERNAL.BO's ROE of +0.01%. Regarding short-term risk, PRAXIS.BO is more volatile compared to ETERNAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check ETERNAL.BO's competition here
PRAXIS.BO vs ZOMATO.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, ZOMATO.NS has a market cap of 2T. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while ZOMATO.NS trades at ₹215.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas ZOMATO.NS's P/E ratio is 286.92. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ZOMATO.NS's ROE of +0.01%. Regarding short-term risk, PRAXIS.BO is more volatile compared to ZOMATO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check ZOMATO.NS's competition here
PRAXIS.BO vs ZOMATO.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, ZOMATO.BO has a market cap of 2T. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while ZOMATO.BO trades at ₹215.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas ZOMATO.BO's P/E ratio is 377.63. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ZOMATO.BO's ROE of +0.01%. Regarding short-term risk, PRAXIS.BO is more volatile compared to ZOMATO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check ZOMATO.BO's competition here
PRAXIS.BO vs SWIGGY.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, SWIGGY.NS has a market cap of 697.3B. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while SWIGGY.NS trades at ₹260.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas SWIGGY.NS's P/E ratio is -14.42. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to SWIGGY.NS's ROE of -0.48%. Regarding short-term risk, PRAXIS.BO is more volatile compared to SWIGGY.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check SWIGGY.NS's competition here
PRAXIS.BO vs SWIGGY.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, SWIGGY.BO has a market cap of 696.1B. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while SWIGGY.BO trades at ₹259.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas SWIGGY.BO's P/E ratio is -14.40. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to SWIGGY.BO's ROE of -0.48%. Regarding short-term risk, PRAXIS.BO is more volatile compared to SWIGGY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check SWIGGY.BO's competition here
PRAXIS.BO vs NYKAA.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, NYKAA.NS has a market cap of 686.2B. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while NYKAA.NS trades at ₹235.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas NYKAA.NS's P/E ratio is 489.08. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to NYKAA.NS's ROE of +0.11%. Regarding short-term risk, PRAXIS.BO is more volatile compared to NYKAA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check NYKAA.NS's competition here
PRAXIS.BO vs NYKAA.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, NYKAA.BO has a market cap of 685.9B. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while NYKAA.BO trades at ₹235.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas NYKAA.BO's P/E ratio is 488.88. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to NYKAA.BO's ROE of +0.11%. Regarding short-term risk, PRAXIS.BO is more volatile compared to NYKAA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check NYKAA.BO's competition here
PRAXIS.BO vs AVL.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, AVL.NS has a market cap of 63.2B. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while AVL.NS trades at ₹478.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas AVL.NS's P/E ratio is 57.22. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to AVL.NS's ROE of +0.19%. Regarding short-term risk, PRAXIS.BO is more volatile compared to AVL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check AVL.NS's competition here
PRAXIS.BO vs REDTAPE.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, REDTAPE.NS has a market cap of 62.4B. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while REDTAPE.NS trades at ₹109.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas REDTAPE.NS's P/E ratio is 29.41. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to REDTAPE.NS's ROE of +0.27%. Regarding short-term risk, PRAXIS.BO is more volatile compared to REDTAPE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check REDTAPE.NS's competition here
PRAXIS.BO vs RTNINDIA.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, RTNINDIA.BO has a market cap of 37.4B. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while RTNINDIA.BO trades at ₹25.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas RTNINDIA.BO's P/E ratio is -9.08. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to RTNINDIA.BO's ROE of -0.38%. Regarding short-term risk, PRAXIS.BO is less volatile compared to RTNINDIA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check RTNINDIA.BO's competition here
PRAXIS.BO vs EMIL.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, EMIL.NS has a market cap of 35.1B. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while EMIL.NS trades at ₹88.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas EMIL.NS's P/E ratio is 37.57. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to EMIL.NS's ROE of +0.06%. Regarding short-term risk, PRAXIS.BO is more volatile compared to EMIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check EMIL.NS's competition here
PRAXIS.BO vs EMIL.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, EMIL.BO has a market cap of 35B. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while EMIL.BO trades at ₹88.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas EMIL.BO's P/E ratio is 37.47. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to EMIL.BO's ROE of +0.06%. Regarding short-term risk, PRAXIS.BO is more volatile compared to EMIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check EMIL.BO's competition here
PRAXIS.BO vs GARGI.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, GARGI.BO has a market cap of 8.2B. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while GARGI.BO trades at ₹768.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas GARGI.BO's P/E ratio is 26.99. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to GARGI.BO's ROE of +0.29%. Regarding short-term risk, PRAXIS.BO is more volatile compared to GARGI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check GARGI.BO's competition here
PRAXIS.BO vs LOGICA.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, LOGICA.BO has a market cap of 3.2B. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while LOGICA.BO trades at ₹181.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas LOGICA.BO's P/E ratio is 22.96. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to LOGICA.BO's ROE of N/A. Regarding short-term risk, PRAXIS.BO is more volatile compared to LOGICA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check LOGICA.BO's competition here
PRAXIS.BO vs KDML.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, KDML.BO has a market cap of 3.1B. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while KDML.BO trades at ₹132.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas KDML.BO's P/E ratio is 15.75. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to KDML.BO's ROE of +0.16%. Regarding short-term risk, PRAXIS.BO is more volatile compared to KDML.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check KDML.BO's competition here
PRAXIS.BO vs PANORAMA.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, PANORAMA.BO has a market cap of 2.7B. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while PANORAMA.BO trades at ₹32.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas PANORAMA.BO's P/E ratio is 24.29. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to PANORAMA.BO's ROE of +0.20%. Regarding short-term risk, PRAXIS.BO is less volatile compared to PANORAMA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check PANORAMA.BO's competition here
PRAXIS.BO vs COMPEAU.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, COMPEAU.BO has a market cap of 2.1B. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while COMPEAU.BO trades at ₹328.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas COMPEAU.BO's P/E ratio is 10.73. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to COMPEAU.BO's ROE of +0.05%. Regarding short-term risk, PRAXIS.BO is more volatile compared to COMPEAU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check COMPEAU.BO's competition here
PRAXIS.BO vs AAYUSH.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, AAYUSH.BO has a market cap of 1.4B. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while AAYUSH.BO trades at ₹27.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas AAYUSH.BO's P/E ratio is 31.41. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to AAYUSH.BO's ROE of +0.54%. Regarding short-term risk, PRAXIS.BO is more volatile compared to AAYUSH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check AAYUSH.BO's competition here
PRAXIS.BO vs LLOYDS.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, LLOYDS.NS has a market cap of 1B. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while LLOYDS.NS trades at ₹39.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas LLOYDS.NS's P/E ratio is -1.53. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to LLOYDS.NS's ROE of N/A. Regarding short-term risk, PRAXIS.BO is less volatile compared to LLOYDS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check LLOYDS.NS's competition here
PRAXIS.BO vs PRAXIS.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, PRAXIS.NS has a market cap of 1B. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while PRAXIS.NS trades at ₹5.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas PRAXIS.NS's P/E ratio is 2.74. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to PRAXIS.NS's ROE of -1.13%. Regarding short-term risk, PRAXIS.BO is more volatile compared to PRAXIS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check PRAXIS.NS's competition here
PRAXIS.BO vs KEMP.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, KEMP.BO has a market cap of 987.2M. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while KEMP.BO trades at ₹913.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas KEMP.BO's P/E ratio is -62.77. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to KEMP.BO's ROE of -0.01%. Regarding short-term risk, PRAXIS.BO is more volatile compared to KEMP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check KEMP.BO's competition here
PRAXIS.BO vs ISFT.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, ISFT.BO has a market cap of 899.6M. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while ISFT.BO trades at ₹55.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas ISFT.BO's P/E ratio is 7.20. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ISFT.BO's ROE of +0.05%. Regarding short-term risk, PRAXIS.BO is more volatile compared to ISFT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check ISFT.BO's competition here
PRAXIS.BO vs ISFT.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, ISFT.NS has a market cap of 898.9M. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while ISFT.NS trades at ₹55.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas ISFT.NS's P/E ratio is 7.19. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ISFT.NS's ROE of +0.05%. Regarding short-term risk, PRAXIS.BO is less volatile compared to ISFT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check ISFT.NS's competition here
PRAXIS.BO vs DIGIDRIVE.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, DIGIDRIVE.NS has a market cap of 651.3M. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while DIGIDRIVE.NS trades at ₹16.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas DIGIDRIVE.NS's P/E ratio is 5.24. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to DIGIDRIVE.NS's ROE of +0.04%. Regarding short-term risk, PRAXIS.BO is less volatile compared to DIGIDRIVE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check DIGIDRIVE.NS's competition here
PRAXIS.BO vs ARCHIES.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, ARCHIES.NS has a market cap of 394.6M. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while ARCHIES.NS trades at ₹11.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas ARCHIES.NS's P/E ratio is -35.39. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ARCHIES.NS's ROE of -0.01%. Regarding short-term risk, PRAXIS.BO is less volatile compared to ARCHIES.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check ARCHIES.NS's competition here
PRAXIS.BO vs ARCHIES.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, ARCHIES.BO has a market cap of 390.8M. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while ARCHIES.BO trades at ₹11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas ARCHIES.BO's P/E ratio is -37.32. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ARCHIES.BO's ROE of -0.01%. Regarding short-term risk, PRAXIS.BO is more volatile compared to ARCHIES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check ARCHIES.BO's competition here
PRAXIS.BO vs PACE.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, PACE.BO has a market cap of 295M. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while PACE.BO trades at ₹12.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas PACE.BO's P/E ratio is 7.19. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to PACE.BO's ROE of +0.05%. Regarding short-term risk, PRAXIS.BO is less volatile compared to PACE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check PACE.BO's competition here
PRAXIS.BO vs DUKEOFS.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, DUKEOFS.BO has a market cap of 251.8M. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while DUKEOFS.BO trades at ₹24.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas DUKEOFS.BO's P/E ratio is -44.81. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to DUKEOFS.BO's ROE of -0.12%. Regarding short-term risk, PRAXIS.BO is more volatile compared to DUKEOFS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check DUKEOFS.BO's competition here
PRAXIS.BO vs UHZAVERI.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, UHZAVERI.BO has a market cap of 125.7M. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while UHZAVERI.BO trades at ₹12.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas UHZAVERI.BO's P/E ratio is -315.25. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to UHZAVERI.BO's ROE of +0.00%. Regarding short-term risk, PRAXIS.BO is less volatile compared to UHZAVERI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check UHZAVERI.BO's competition here
PRAXIS.BO vs DARSHANORNA.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, DARSHANORNA.BO has a market cap of 121.8M. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while DARSHANORNA.BO trades at ₹2.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas DARSHANORNA.BO's P/E ratio is 50.40. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to DARSHANORNA.BO's ROE of +0.03%. Regarding short-term risk, PRAXIS.BO is more volatile compared to DARSHANORNA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check DARSHANORNA.BO's competition here
PRAXIS.BO vs RAJPUTANA.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, RAJPUTANA.BO has a market cap of 95.9M. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while RAJPUTANA.BO trades at ₹31.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas RAJPUTANA.BO's P/E ratio is 77.87. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to RAJPUTANA.BO's ROE of +0.03%. Regarding short-term risk, PRAXIS.BO is more volatile compared to RAJPUTANA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check RAJPUTANA.BO's competition here
PRAXIS.BO vs DDIL.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, DDIL.BO has a market cap of 95.1M. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while DDIL.BO trades at ₹1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas DDIL.BO's P/E ratio is 4.42. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to DDIL.BO's ROE of +0.26%. Regarding short-term risk, PRAXIS.BO is more volatile compared to DDIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check DDIL.BO's competition here
PRAXIS.BO vs HARIAEXPO.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, HARIAEXPO.BO has a market cap of 84.9M. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while HARIAEXPO.BO trades at ₹6.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas HARIAEXPO.BO's P/E ratio is 61.25. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to HARIAEXPO.BO's ROE of +0.01%. Regarding short-term risk, PRAXIS.BO is less volatile compared to HARIAEXPO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check HARIAEXPO.BO's competition here
PRAXIS.BO vs VEERKRUPA.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, VEERKRUPA.BO has a market cap of 70.8M. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while VEERKRUPA.BO trades at ₹0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas VEERKRUPA.BO's P/E ratio is 27.00. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to VEERKRUPA.BO's ROE of +0.01%. Regarding short-term risk, PRAXIS.BO is more volatile compared to VEERKRUPA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check VEERKRUPA.BO's competition here
PRAXIS.BO vs MHSGRMS.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, MHSGRMS.BO has a market cap of 52.7M. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while MHSGRMS.BO trades at ₹6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas MHSGRMS.BO's P/E ratio is 7.79. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to MHSGRMS.BO's ROE of -2.38%. Regarding short-term risk, PRAXIS.BO is more volatile compared to MHSGRMS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check MHSGRMS.BO's competition here
PRAXIS.BO vs JSHL.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, JSHL.BO has a market cap of 52.4M. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while JSHL.BO trades at ₹8.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas JSHL.BO's P/E ratio is -11.88. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to JSHL.BO's ROE of -0.02%. Regarding short-term risk, PRAXIS.BO is more volatile compared to JSHL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check JSHL.BO's competition here
PRAXIS.BO vs SPECTRA.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, SPECTRA.BO has a market cap of 37.7M. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while SPECTRA.BO trades at ₹5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas SPECTRA.BO's P/E ratio is -1.53. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to SPECTRA.BO's ROE of +0.07%. Regarding short-term risk, PRAXIS.BO is more volatile compared to SPECTRA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check SPECTRA.BO's competition here
PRAXIS.BO vs PRAXIS-RE.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1B. In comparison, PRAXIS-RE.NS has a market cap of 0. Regarding current trading prices, PRAXIS.BO is priced at ₹5.60, while PRAXIS-RE.NS trades at ₹15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 2.73, whereas PRAXIS-RE.NS's P/E ratio is N/A. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to PRAXIS-RE.NS's ROE of N/A. Regarding short-term risk, PRAXIS.BO is less volatile compared to PRAXIS-RE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check PRAXIS-RE.NS's competition here